Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q2)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q2)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash, cash equivalents and federal funds sold | 2,775.50%7.35M | -80.02%89.7K | -80.02%89.7K | -62.51%255.63K | 156.80%449.06K | 156.80%449.06K | 199.51%681.78K | -17.99%174.87K | -17.99%174.87K | 115.35%227.63K |
| -Cash and cash equivalents | 2,775.50%7.35M | -80.02%89.7K | -80.02%89.7K | -62.51%255.63K | 156.80%449.06K | 156.80%449.06K | 199.51%681.78K | -17.99%174.87K | -17.99%174.87K | 115.35%227.63K |
| -Available for sale securities | -59.65%4.09M | ---- | ---- | --10.15M | ---- | ---- | ---- | -28.38%195.59M | ---- | ---- |
| -Short term investments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 204.94%186M | ---- | ---- |
| Long term equity investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -4.26%276.71M | ---- | ---- |
| Derivative assets | ---- | --0 | --0 | -42.40%12.47K | --91.12K | --91.12K | --21.65K | --0 | --0 | --0 |
| Receivables | 2,097.93%260.94K | 452.80%76K | 452.80%76K | -0.50%11.87K | -18.43%13.75K | -18.43%13.75K | -9.10%11.93K | -13.90%16.85K | -13.90%16.85K | -54.22%13.13K |
| -Accounts receivable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -68.74%15.88M | ---- | ---- |
| -Due from related parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.52M | ---- | ---- |
| Prepaid assets | --147.71K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Goodwill and other intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%3.52M | ---- | ---- |
| -Goodwill | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%3.52M | ---- | ---- |
| Total assets | 451.82%57.55M | 78.66%17.88M | 78.66%17.88M | 4.59%10.43M | -2.67%10.01M | -2.67%10.01M | -4.76%9.97M | -18.52%10.28M | -18.52%10.28M | -20.46%10.47M |
| Liabilities | ||||||||||
| Current accrued expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.39%2.71M | ---- | ---- |
| Derivative product liabilities | --390.35K | ---- | ---- | ---- | ---- | ---- | --0 | -67.56%22.67K | -67.56%22.67K | -30.05%45.78K |
| Payables | ---- | ---- | ---- | 325.78%2.3M | ---- | ---- | 211.22%540.46K | -50.38%21.72M | ---- | -83.99%173.66K |
| -Accounts payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -16.65%7.78M | ---- | ---- |
| -Other payable | ---- | ---- | ---- | 325.78%2.3M | ---- | ---- | 211.22%540.46K | -46.10%13.94M | ---- | -83.99%173.66K |
| Preferred securities outside stock equity | 689.43%35.26M | 19.37%10.29M | 19.37%10.29M | -48.21%4.47M | -5.45%8.62M | -5.45%8.62M | -5.45%8.62M | -1.67%9.12M | -1.67%9.12M | -1.67%9.12M |
| Other liabilities | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 | 0.00%100 |
| Total liabilities | 422.82%35.76M | 18.95%10.36M | 18.95%10.36M | -25.76%6.84M | -5.67%8.71M | -5.67%8.71M | -1.90%9.21M | -2.17%9.23M | -2.17%9.23M | -10.40%9.39M |
| Shareholders'equity | ||||||||||
| Share capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%25K | ---- | ---- |
| -common stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%25K | ---- | ---- |
| -Preferred stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Additional paid-in capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.91%999.05M | ---- | ---- |
| Retained earnings | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -77.90%15.13M | ---- | ---- |
| Less: treasury stock | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 2.12%124M | ---- | ---- |
| Total stockholders'equity | 507.08%21.79M | 478.04%7.52M | 478.04%7.52M | 374.12%3.59M | 23.63%1.3M | 23.63%1.3M | -29.71%756.92K | -66.95%1.05M | -66.95%1.05M | -59.81%1.08M |
| Noncontrolling interests | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 680.47%10.19M | ---- | ---- |
| Total equity | 507.08%21.79M | 478.04%7.52M | 478.04%7.52M | 374.12%3.59M | 23.63%1.3M | 23.63%1.3M | -29.71%756.92K | -66.95%1.05M | -66.95%1.05M | -59.81%1.08M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.